Cash for access
The Department of Health has allocated over £650m a year to a five-year strategy to give patients better access to new medicines and treatments, and to support researchers conducting health and social care research throughout England. Part of the scheme will mean that every patient in England will haveaccess to clinical trials and have the opportunity to participate in studies.
Citation: The Pharmaceutical Journal URI: 10020820
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com